Repligen Corporation - Asset Resilience Ratio
Repligen Corporation (RGEN) has an Asset Resilience Ratio of 6.90% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Repligen Corporation (RGEN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how Repligen Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see RGEN current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Repligen Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Repligen Corporation long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $203.67 Million | 6.9% |
| Total Liquid Assets | $203.67 Million | 6.90% |
Asset Resilience Insights
- Limited Liquidity: Repligen Corporation maintains only 6.90% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Repligen Corporation Industry Peers by Asset Resilience Ratio
Compare Repligen Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0 |
Medical Instruments & Supplies | 0.37% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Amplitude Surgical SAS
PA:AMPLI |
Medical Instruments & Supplies | 0.71% |
|
Suzhou Iron Technology Co. Ltd. A
SHG:688329 |
Medical Instruments & Supplies | 0.36% |
|
DIO Corporation
KQ:039840 |
Medical Instruments & Supplies | 8.52% |
Annual Asset Resilience Ratio for Repligen Corporation (1999–2025)
The table below shows the annual Asset Resilience Ratio data for Repligen Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.83% | $201.61 Million | $2.95 Billion | +5.89pp |
| 2024-12-31 | 0.94% | $26.61 Million | $2.83 Billion | -- |
| 2023-12-31 | 0.00% | $0.00 | $2.82 Billion | -- |
| 2022-12-31 | 3.96% | $100.30 Million | $2.53 Billion | -- |
| 2021-12-31 | 0.00% | $0.00 | $2.36 Billion | -- |
| 2017-12-31 | 0.00% | $0.00 | $120.41 Million | -- |
| 2016-12-31 | 6.77% | $19.55 Million | $288.91 Million | -5.33pp |
| 2015-12-31 | 12.09% | $17.68 Million | $146.24 Million | -6.28pp |
| 2013-12-31 | 18.37% | $21.79 Million | $118.64 Million | +7.19pp |
| 2012-12-31 | 11.18% | $10.85 Million | $97.01 Million | -9.06pp |
| 2011-12-31 | 20.24% | $15.40 Million | $76.10 Million | -28.76pp |
| 2010-12-31 | 49.00% | $35.42 Million | $72.29 Million | -7.86pp |
| 2009-12-31 | 56.86% | $40.61 Million | $71.42 Million | -2.55pp |
| 2008-12-31 | 59.41% | $43.82 Million | $73.75 Million | +34.39pp |
| 2007-12-31 | 25.02% | $17.22 Million | $68.84 Million | -26.23pp |
| 2006-12-31 | 51.25% | $14.90 Million | $29.08 Million | +4.23pp |
| 2005-12-31 | 47.02% | $13.45 Million | $28.60 Million | -3.67pp |
| 2004-12-31 | 50.69% | $13.99 Million | $27.61 Million | +16.93pp |
| 2003-12-31 | 33.75% | $10.00 Million | $29.61 Million | +6.07pp |
| 2002-12-31 | 27.68% | $9.18 Million | $33.15 Million | -14.03pp |
| 2001-12-31 | 41.71% | $12.14 Million | $29.11 Million | +17.53pp |
| 2000-12-31 | 24.18% | $7.77 Million | $32.15 Million | -0.09pp |
| 1999-12-31 | 24.27% | $8.81 Million | $36.29 Million | -- |
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, … Read more